F. RABI, “ EFFECT OF DAPAGLIFLOZIN ON CARDIOVASCULAR OUTCOMES IN HFREF PATIENTS: IMPACT OF DIABETES MELLITUS TYPE 2 STATUS”, Biol Clin Sci Res J, vol. 2024, no. 1, p. 830, May 2024.